Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Eledon Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −5 vs. Q2 2023
- Shares held
- 8.92M
- −357.8K (−3.9%) vs. Q2 2023
- Total value
- $12.2M
- −$490.8K (−3.9%) vs. Q2 2023
- New holders
- 3
- 8 more added
- Sold out
- 8
- 9 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 161 | $184.6M |
| Q1 2026 | 121 | $131.2M |
| Q4 2025 | 95 | $66.7M |
| Q3 2025 | 83 | $94.5M |
| Q2 2025 | 85 | $110.7M |
| Q1 2025 | 83 | $130.3M |
| Q4 2024 | 75 | $158.5M |
| Q3 2024 | 33 | $46.0M |
| Q2 2024 | 32 | $48.2M |
| Q1 2024 | 29 | $19.8M |
| Q4 2023 | 29 | $16.5M |
| Q3 2023 | 28 | $12.2M |
| Q2 2023 | 33 | $12.7M |
| Q1 2023 | 30 | $14.7M |
| Q4 2022 | 28 | $14.4M |
| Q3 2022 | 31 | $17.3M |
| Q2 2022 | 31 | $15.9M |
| Q1 2022 | 32 | $27.6M |
| Q4 2021 | 36 | $34.7M |
| Q3 2021 | 35 | $52.1M |
| Q2 2021 | 34 | $74.5M |
| Q1 2021 | 34 | $89.0M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Eledon Pharmaceuticals, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 26 | $36 | 0.00% | +26 | New |
| Wells Fargo & Company | 172 | $236 | 0.00% | +26+17.8% | Added |
| Morgan Stanley | 2,155 | $2.95K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 3,623 | $4.00K | 0.00% | +3,403+1,546.8% | Added |
| Group One Trading, L.P. | 4,850 | $6.64K | 0.00% | −1,068−18.0% | Reduced |
| Tower Research Capital LLC (TRC) | 8,443 | $11.6K | 0.00% | −3,007−26.3% | Reduced |
| RMB Capital Management, LLC | 10,000 | $13.7K | 0.00% | +10,000 | New |
| Pathstone Family Office, LLC | 13,029 | $17.9K | 0.00% | +13,029 | New |
| Two Sigma Advisers, LP | 13,100 | $17.9K | 0.00% | −9,900−43.0% | Reduced |
| SVB Financial Group | 13,472 | $18.5K | 0.03% | −4,553−25.3% | Reduced |
| Charles Schwab Investment Management Inc | 14,987 | $20.5K | 0.00% | 00.0% | Unchanged |
| Mercer Global Advisors Inc | 16,726 | $23.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 27,150 | $37.2K | 0.00% | −15,852−36.9% | Reduced |
| BlackRock Inc. | 28,302 | $38.8K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 44,692 | $61.2K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 47,428 | $65.0K | 0.00% | +17,375+57.8% | Added |
| Ingalls & Snyder LLC | 51,849 | $71.0K | 0.00% | +1,000+2.0% | Added |
| Susquehanna International Group, LLP | 56,576 | $77.5K | 0.00% | +6,074+12.0% | Added |
| Jmac Enterprises LLC | 58,041 | $79.5K | 0.02% | −22,000−27.5% | Reduced |
| Renaissance Technologies LLC | 61,973 | $85.0K | 0.00% | +1,600+2.7% | Added |
| Royal Bank of Canada | 158,207 | $217.0K | 0.00% | −115,138−42.1% | Reduced |
| Geode Capital Management, LLC | 176,039 | $241.3K | 0.00% | +6,389+3.8% | Added |
| CM Management, LLC | 234,803 | $321.7K | 0.34% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 443,001 | $606.9K | 0.00% | 00.0% | Unchanged |
| Woodline Partners LP | 603,993 | $827.5K | 0.01% | +87,318+16.9% | Added |
| Vanguard Group Inc | 674,520 | $924.1K | 0.00% | −5,037−0.7% | Reduced |
| Armistice Capital, LLC | 1,824,000 | $2.50M | 0.07% | −18,803−1.0% | Reduced |
| BVF Inc | 4,326,710 | $5.93M | 0.16% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −221,830−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −22,050−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −17,675−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −15,783−100.0% | Sold out |
| Veritable, L.P. | 0 | $0 | 0.00% | −13,029−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −10,586−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −7,740−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −32−100.0% | Sold out |